New and emerging approaches to lipid lowering

Sponsored by Amgen Australia Pty Ltd

In this episode Professor Stephen Nicholls and the expert panel explore where we are now with newer therapies to reduce cardiovascular risk, before taking a peek into the future to see what the next few years will bring. This is an excerpt from a recent Amgen One Cardiovascular Academy live webcast, hosted by Professor Stephen Nicholls ...

Already a member?

Login to keep reading.

© 2021 the limbic